Avacta enters research collaboration with OncoSec
Avacta Group
48.80p
16:49 26/04/24
8.44%
3.80p
Avacta Group announced on Monday that it and OncoSec Medical Incorporated have entered into a research collaboration to combine Avacta's ‘Affimer’ protein platform with OncoSec's gene delivery technology ‘ImmunoPulse’.
FTSE AIM All-Share
755.28
17:14 26/04/24
n/a
n/a
Pharmaceuticals & Biotechnology
22,773.26
16:59 26/04/24
0.10%
22.78